Cellebrite DI (CLBT) Share-based Compensation (2021 - 2025)
Cellebrite DI's Share-based Compensation history spans 5 years, with the latest figure at $12.0 million for Q4 2025.
- Quarterly Share-based Compensation rose 29.43% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.6 million through Dec 2025, up 49.24% year-over-year, with the annual reading at $44.9 million for FY2025, 46.83% up from the prior year.
- Share-based Compensation came in at $12.0 million for Q4 2025, down from $15.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $15.3 million in Q3 2025 to a low of $1.4 million in Q3 2021.
- The 5-year median for Share-based Compensation is $4.6 million (2023), against an average of $5.6 million.
- Year-over-year, Share-based Compensation skyrocketed 144.04% in 2022 and then grew 27.6% in 2023.
- Cellebrite DI's Share-based Compensation stood at $1.7 million in 2021, then soared by 128.0% to $3.8 million in 2022, then soared by 33.61% to $5.1 million in 2023, then surged by 83.18% to $9.3 million in 2024, then increased by 29.43% to $12.0 million in 2025.
- Per Business Quant, the three most recent readings for CLBT's Share-based Compensation are $12.0 million (Q4 2025), $15.3 million (Q3 2025), and $9.3 million (Q4 2024).